Focus Partners Advisor Solutions LLC Purchases New Position in Globe Life Inc. $GL

Focus Partners Advisor Solutions LLC purchased a new position in Globe Life Inc. (NYSE:GL) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 5,867 shares of the company’s stock, valued at approximately $1,048,000.

A number of other hedge funds also recently bought and sold shares of the business. Hilton Head Capital Partners LLC purchased a new stake in shares of Globe Life in the fourth quarter valued at approximately $30,000. CYBER HORNET ETFs LLC acquired a new stake in Globe Life in the 2nd quarter valued at $28,000. MUFG Securities EMEA plc purchased a new stake in Globe Life in the 2nd quarter worth $31,000. Torren Management LLC purchased a new stake in Globe Life in the 4th quarter worth $37,000. Finally, AdvisorNet Financial Inc raised its position in Globe Life by 41.1% during the first quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock worth $44,000 after acquiring an additional 92 shares during the period. Hedge funds and other institutional investors own 81.61% of the company’s stock.

Insider Transactions at Globe Life

In other Globe Life news, CEO Frank M. Svoboda sold 20,000 shares of the stock in a transaction on Friday, May 22nd. The shares were sold at an average price of $156.68, for a total transaction of $3,133,600.00. Following the completion of the sale, the chief executive officer owned 54,020 shares of the company’s stock, valued at $8,463,853.60. This represents a 27.02% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Michael Clay Majors sold 37,000 shares of the firm’s stock in a transaction on Wednesday, July 29th. The stock was sold at an average price of $178.64, for a total transaction of $6,609,680.00. Following the completion of the sale, the executive vice president directly owned 53,518 shares in the company, valued at approximately $9,560,455.52. This trade represents a 40.88% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 191,747 shares of company stock valued at $33,480,408. 2.11% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

GL has been the topic of several recent analyst reports. JPMorgan Chase & Co. increased their price objective on shares of Globe Life from $181.00 to $201.00 and gave the company an “overweight” rating in a report on Tuesday, July 21st. Jefferies Financial Group upped their price target on shares of Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a research report on Friday, July 10th. Keefe, Bruyette & Woods lowered their price objective on Globe Life from $192.00 to $190.00 and set an “outperform” rating on the stock in a report on Friday, July 24th. Piper Sandler boosted their price objective on Globe Life from $175.00 to $200.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 15th. Finally, TD Cowen increased their target price on Globe Life from $215.00 to $225.00 and gave the company a “buy” rating in a report on Wednesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $191.67.

Globe Life Stock Down 0.1%

GL opened at $180.87 on Monday. The company has a market cap of $13.90 billion, a P/E ratio of 12.01 and a beta of 0.48. The business’s 50-day moving average price is $177.16 and its 200-day moving average price is $157.41. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.43. Globe Life Inc. has a 12 month low of $127.85 and a 12 month high of $191.55.

Globe Life (NYSE:GL) last issued its earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share for the quarter, missing the consensus estimate of $3.67 by ($0.06). Globe Life had a net margin of 19.58% and a return on equity of 20.52%. The company had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.59 billion. During the same quarter in the prior year, the company earned $3.05 earnings per share. The company’s revenue was up 8.0% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. On average, equities analysts expect that Globe Life Inc. will post 15.71 EPS for the current year.

Globe Life declared that its Board of Directors has initiated a share repurchase plan on Monday, August 10th that allows the company to buyback $2.50 billion in outstanding shares. This buyback authorization allows the company to reacquire up to 17.7% of its stock through open market purchases. Stock buyback plans are often an indication that the company’s board of directors believes its shares are undervalued.

Globe Life Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Monday, October 5th will be issued a $0.33 dividend. The ex-dividend date is Monday, October 5th. This represents a $1.32 annualized dividend and a dividend yield of 0.7%. Globe Life’s dividend payout ratio (DPR) is currently 8.76%.

Globe Life Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.